Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Celltrion Healthcare Hungary Kft. and AbbVie Deutschland GmbH & Co. KG, against the decision of the State Institute for Drug Control from 23. 5. 2019, under the no. SUKLS256885/2017:

• the decision under appeal is partially reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.